JAMA Medical News
JAMA Medical News features discussions of timely topics in clinical medicine, biomedical research, public health, and health policy, as covered in the Medical News section of JAMA, the Journal of the American Medical Association.
Episodes
The Black Market for Investigational GLP-1 Drugs
JAMA Medical News Associate Managing Editor Kate Schweitzer and Lead Senior Staff Writer Rita Rubin discuss "Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Bargain." Related Content: Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Bargain
What Happens When Children Use AI for Support?
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss 1 in 5 Children Report Using AI for Emotional Support--Is It Good News or Bad? Related Content: More Than 1 in 5 Children Report Using AI for Emotional Support—Is It Good News or Bad?
Ovarian Cancer Is a Misnomer
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Remove the Fallopian Tubes If the Opportunity Arises, ACOG Says in New Ovarian Cancer Prevention Guidance." Related Content: Remove the Fallopian Tubes If the Opportunity Arises, ACOG Says in New Ovarian Cancer Prevention Guidance
The Challenge of Diagnosing Adult ADHD
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "As More Adults Seek ADHD Care, Primary Care Clinicians Are Tasked With Getting the Diagnosis Right." Related Content: As More Adults Seek ADHD Care, Primary Care Clinicians Are Tasked With Getting the Diagnosis Right
Researchers Turn to Viruses to Treat UTIs
JAMA Medical News Director Jennifer Abbasi and Staff Writer Samantha Anderer discuss "Is Phage Therapy the Next Big Hope for Urinary Tract Infections?" Related Content: Is Phage Therapy the Next Big Hope for Urinary Tract Infections?
A New Definition of MI and Other Heart Health Highlights From ESC Congress 2026
Hear about a new universal definition of myocardial infarction, updated heart failure guidelines, and other clinical highlights in this interview with Tomasz Guzik, MD, PhD, chair of this year's European Society of Cardiology Congress. Related Content: A New Universal Definition of MI, Blood Pressure and Dementia, and More News From ESC Congress 2026
The Fascinating Road to a New Narcolepsy Treatment
The winners of the 2026 Albert Lasker Basic Medical Research Award, Emmanuel Mignot, MD, PhD, and Masashi Yanagisawa, MD, PhD, discuss how they identified the neuropeptide orexin and deduced its role in narcolepsy. Related Content: How the Albert Lasker Winners Identified Orexin and Elucidated the Peptide's Role in Narcolepsy
What the Latest Research Says About Preventing Dementia
JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "Nearly Half of Dementia Cases May Be Preventable—Here's What the Research Says So Far." Related Content: Nearly Half of Dementia Cases May Be Preventable—Here's What the Research Says So Far
Considering Cognition and Frailty in Cardiovascular Care—Too Big an Ask?
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Cardiovascular Care Should Incorporate Cognition and Frailty, Heart Group Says in New Statement." Related Content: Cardiovascular Care Should Incorporate Cognition and Frailty, Heart Group Says in New Statement
The Tip of the Iceberg Lettuce
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "What the Cyclospora Outbreak Reveals About the State of US Foodborne Disease Surveillance." Related Content: What the Cyclospora Outbreak Reveals About the State of US Foodborne Disease Surveillance
FDA Approves the First mRNA Flu Vaccine for the US
JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "What to Know About the mRNA Flu Vaccine, Newly Approved by the FDA." Related Content: What to Know About the mRNA Flu Vaccine, Newly Approved by the FDA
The Slow Evolution of Lyme Disease Care
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Will New Lyme Disease Approaches Change Patient Care?" Related Content: Will New Lyme Disease Approaches Change Patient Care?
Highlights From the 2026 Alzheimer's Association International Conference
Hear the latest on blood-based biomarkers, lifestyle interventions, and more from AAIC 2026 with Gil Rabinovici, MD. Related Content: Soccer Players' Brains, P-Tau217 Blood Tests, Lifestyle and Dementia Risk, and More From AAIC 2026
Striking the Balance for Prescribing Opioids
JAMA Medical News Associate Managing Editor Kate Schweitzer and Staff Writer Samantha Anderer discuss "A Decade After the CDC's Opioid Prescribing Guidelines, Have Clinicians Struck the Right Balance?" Related Content: A Decade After the CDC's Opioid Prescribing Guidelines, Have Clinicians Struck the Right Balance?
The Menopause Treatment Boom
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Wild West or Gold Rush: How Long-Neglected Menopause Care Has Spawned a Booming Marketplace." Related Content: Wild West or Gold Rush: How Long-Neglected Menopause Care Has Spawned a Booming Marketplace
The First CKM Syndrome Guidelines Are Here
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "What to Know About the First CKM Syndrome Guidelines." Related Content: What to Know About the First CKM Syndrome Guidelines
The Testosterone Therapy Debate
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Testosterone Therapy: Does New Evidence Warrant Broader Prescribing?" Related Content: Testosterone Therapy: Does New Evidence Warrant Broader Prescribing?
Alzheimer Disease Blood Test May Have Higher Rate of False Positives Than Expected
JAMA Medical News Associate Managing Editor Kate Schweitzer and Lead Senior Staff Writer Rita Rubin discuss "First Alzheimer Disease Blood Test May Produce Many False-Positive Results, Study Finds." Related Content: First Alzheimer Disease Blood Test May Produce Many False-Positive Results, Study Finds
PMOS is the New PCOS
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "PCOS is Now PMOS—Will a New Name Translate to Improved Clinical Care?" Related Content: PCOS Is Now PMOS—Will a New Name Translate to Improved Clinical Care?
New GLP-1 Drug Options and More Highlights From the ADA's 2026 Scientific Sessions
Rita Kalyani, MD, chief scientific and medical officer at the American Diabetes Association, discusses the latest diabetes and obesity research, including a novel oral GLP-1 drug, a combined semaglutide-amylin analogue injection, data from China on high-dose mazdutide, and more. Related Content: A New GLP-1 Pill for Diabetes, Semaglutide With Amylin, Data From China, and More From ADA 2026
Why Exercise Still Matters in the GLP-1 Drug Era
JAMA Medical News Director Jennifer Abbasi and Staff Writer Samantha Anderer discuss "In Obesity Treatment, Physical Activity's Benefits Go Beyond Weight Loss, Says AHA." Related Content: In Obesity Treatment, Physical Activity's Benefits Go Beyond Weight Loss, Says AHA
The Search for a Fentanyl Vaccine
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Inside the Push for a Fentanyl Vaccine." Related Content: Inside the Push for a Fentanyl Vaccine
New Insights on HFpEF in Patients With Severe Obesity
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "HFpEF May Be a Different Disease in Patients With Severe Obesity." Related Content: HFpEF May Be a Different Disease in Patients With Severe Obesity
Ebola Outbreak Update
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "A Rare Ebola Virus Is Spreading in the DRC—Here's What to Know." Related Content: A Rare Ebola Virus Is Spreading in the DRC—Here's What to Know
Is There a Doctor on the Ship?
Joining from quarantine, Stephen Kornfeld, MD, discusses his experience stepping in as the ship's physician when hantavirus transformed his vacation cruise into a global public health concern. Related Content: Hantavirus Outbreak: First Test of US Public Health Response After WHO Withdrawal When Hantavirus Sickened the Ship's Physician, Stephen Kornfeld, MD, Stepped Up
Bangladesh's New Measles Crisis
JAMA Medical News Director Jennifer Abbasi and Staff Writer Samantha Anderer discuss "More Than 19 000 Measles Cases in a Month—What the Current Outbreak in Bangladesh Signals to the World." Related Content: More Than 19 000 Measles Cases in a Month—What the Current Outbreak in Bangladesh Signals to the World
New Obesity Definition Stirs Debate
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Experts Debate How Obesity Should Be Defined and Diagnosed." Related Content: Experts Debate How Obesity Should Be Defined and Diagnosed
Multi-Cancer Blood Tests Have Arrived
JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "These Blood Tests May Detect Dozens of Cancers, but Will They Save Lives?" Related Content: These Blood Tests May Detect Dozens of Cancers, but Will They Save Lives?
Why GLP-1 Drugs Affect Patients Differently
JAMA Medical News Associate Managing Editor Kate Schweitzer and Staff Writer Samantha Anderer discuss "Weight Loss, Adverse Effects With GLP-1 Medications May Be Influenced by Genetics." Related Content: Weight Loss, Adverse Effects With GLP-1 Medications May Be Influenced by Genetics
Treating Methamphetamine Use Disorder With an Antidepressant
JAMA Medical News Associate Managing Editor Kate Schweitzer and Staff Writer Samantha Anderer discuss "Could a Common Antidepressant Help Treat Methamphetamine Use Disorder?" Related Content: Could a Common Antidepressant Help Treat Methamphetamine Use Disorder?
Cicada, the SARS-CoV-2 Variant With a Surprising Trajectory
JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "What to Know About Cicada, or BA.3.2, the Latest SARS-CoV-2 Variant Under Monitoring." Related Content: What to Know About Cicada, or BA.3.2, the Latest SARS-CoV-2 Variant Under Monitoring
Highlights From the American College of Cardiology's 2026 Scientific Sessions
Hear the latest on PCSK9 inhibitors, cardiorenal benefits of GLP-1 drugs, and other clinical research in this interview with Katie Berlacher, MD, MS, chair of this year's annual ACC meeting. Related Content: PCSK9 Inhibitors in Diabetes, Tirzepatide's Cardiorenal Effects, Shingles Vaccine, and More From ACC
Cancer-Treating Vaccines Are on the Horizon
JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "How mRNA Vaccines Could Help Treat Cancer." Related Content: How mRNA Vaccines Could Help Treat Cancer
What Happens When Patients With Decompensated Cirrhosis Stop Drinking?
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "New Hope for Patients With Advanced Alcohol-Related Cirrhosis Who Stop Drinking." Related Content: New Hope for Patients With Advanced Alcohol-Related Cirrhosis Who Stop Drinking
What's New in the Updated Lipid Guidelines?
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "What to Know About the New Lipid Guidelines." Related Content: What to Know About the New Lipid Guidelines
The Health Costs of EPA's Heavy Metal Air Pollution Rollbacks
JAMA Medical News Associate Managing Editor Kate Schweitzer and Staff Writer Samantha Anderer discuss "Why the EPA's Reversal on Heavy Metal Air Pollution Is Cause for Concern." Related Content: Why the EPA's Reversal on Heavy Metal Air Pollution Is Cause for Concern
PrEP Prevents HIV—If Patients Can Get It
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "After a Decade of Progress Against HIV, PrEP Enters a Precarious Era." Related Content: After a Decade of Progress Against HIV, PrEP Enters a Precarious Era
AI Tools for Patients Have Arrived
JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "Are AI Tools Ready to Answer Patients' Questions About Their Medical Care?" Related Content: Are AI Tools Ready to Answer Patients' Questions About Their Medical Care?
Why the Low Carb vs Low Fat Debate Misses the Point
JAMA Medical News Associate Managing Editor Kate Schweitzer and Staff Writer Samantha Anderer discuss "In the Low-Carb vs Low-Fat Debate, Study Suggests Food Quality Matters More for Heart Health." Related Content: In the Low-Carb vs Low-Fat Debate, Study Suggests Food Quality Matters More for Heart Health
What's New in the Dietary Guidelines for Americans?
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "What Nutrition Experts Say About the New Dietary Guidelines for Americans." Related Content: What Nutrition Experts Say About the New Dietary Guidelines for Americans
ICE Raids Are Jeopardizing Health Care Access
JAMA Medical News Associate Managing Editor Kate Schweitzer and Lead Senior Staff Writer Rita Rubin discuss "US Patients Getting ICE-d-Out of Health Care." Related Content: US Patients Getting ICEd-Out of Health Care
Understanding COVID-19 Vaccine–Associated Myocarditis
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Mechanisms Are Emerging for COVID-19 Vaccine−Associated Myocarditis." Related Content: Mechanisms Are Emerging for COVID-19 Vaccine−Associated Myocarditis
What's Next in Weight-Loss Drugs?
JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "Data on 3 New GLP-1 Drugs for Weight Loss That May Be Approved This Year." Related Content: Data on 3 New GLP-1 Drugs for Weight Loss That May Be Approved This Year
How Stress May Connect Mental Health and Cardiovascular Disease
In this week's roundup, Associate Managing Editor Kate Schweitzer and Lead Senior Staff Writer Rita Rubin discuss "Stress May Link Depression and Anxiety to Cardiovascular Disease." Related Content: Stress May Link Depression and Anxiety to Cardiovascular Disease
FDA Approves the First Oral GLP-1 Drug for Obesity
In this week's roundup, JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "What to Know About the Wegovy Pill for Obesity" and more. Related Content: What to Know About the Wegovy Pill for Obesity
Understanding the World Health Organization's GLP-1 Guidelines
In this week's roundup, JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "What to Know About the WHO's New GLP-1 Guideline" and more. Related Content: What to Know About the WHO's New GLP-1 Drug Guideline
Are Nicotine Pouches a Safer Alternative to Cigarettes?
In this week's roundup, JAMA Medical News Director Jennifer Abbasi and staff writer Samantha Anderer discuss "Can Nicotine Pouches Help People Quit Smoking?" and more. Related Content: Can Nicotine Pouches Help People Quit Smoking?
The Push for Geriatrics Education
In this week's roundup, JAMA Medical News Associate Managing Editor Kate Schweitzer and freelance writer and Harvard medical student Emily Harris discuss "A Growing Movement Aims to Prepare All Physicians to Care for Older Adults" and more. Related Content: A Growing Movement Aims to Prepare All Physicians to Care for Older Adults
JAMA Research of the Year With Editor in Chief Kirsten Bibbins-Domingo
In this episode, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, and Medical News Director Jennifer Abbasi discuss the journal's inaugural Research of the Year roundup. Related Content: Research of the Year 2025
Cardiovascular Highlights From AHA Scientific Sessions 2025
Updates on coffee and AFib, a polypill approach for HFrEF, the first oral PCSK9 inhibitor, vitamin D supplementation for secondary prevention, and more: Joanna Chikwe, MD, chair of the American Heart Association's Scientific Sessions conference and of the Department of Cardiac Surgery in the Smidt Heart Institute at Cedars-Sinai Medical Center, shares clinical research highlights from the recent m
Alzheimer Disease Blood Test Approved for Primary Care
Correction: an earlier version of this podcast misstated the phosphorylated tau analyte measured by the Roche blood biomarker test. It is p-tau181, not p-tau217. In this week's roundup, JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "Alzheimer Disease Blood Test Cleared for Primary Care, but Questions Remain About Its Use" and more. Related Content: Al
Highlights From Kidney Week 2025
Updates on SGLT2 inhibitors, fish oil and hemodialysis, GLP-1 drugs, and more: Katherine R. Tuttle, MD, education committee co-chair of Kidney Week 2025 and a professor of medicine at the University of Washington, shares clinical research highlights from the recent meeting. Related Content: SGLT2 Inhibitors, Fish Oil in Hemodialysis, GLP-1 Drugs, and More—Highlights From Kidney Week
US Governors Form a Public Health Alliance
In this week's roundup, JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "US Governors Are Forming a Public Health Alliance Amid Federal Funding Cuts and Shifting Guidance" and more. Related Content: US Governors Are Forming a Public Health Alliance Amid Federal Funding Cuts and Shifting Guidance
The Common Liver Disease You've Never Heard Of
In this weekly roundup, JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "MASLD—The Chronic Liver Disease That Affects Tens of Millions of US Adults but Flies Under the Radar" and more. Related Content: Metabolic Dysfunction–Associated Steatotic Liver Disease in Adults MASLD—The Chronic Liver Disease That Affects Tens of Millions of US Adults but Flies U
Are Peanut Allergies Finally on the Decline?
In this weekly roundup, JAMA Medical News Director Jennifer Abbasi and Staff Writer Samantha Anderer discuss "Peanut Allergies Appear to Be on the Decline Following Early Introduction Guidelines" and more. Related Content: Peanut Allergies Appear to Be on the Decline Following Early Introduction Guidelines
Dementia's Cultural Narratives
Dementia is still a highly stigmatized condition. Nancy Berlinger, PhD, a senior research scholar at The Hastings Center for Bioethics, discusses a new report about the cultural narratives of dementia and how they can affect the quality of life and the care of patients with the condition. Related Content: Living With Dementia Report Emphasizes That Even Those With Advanced Disease Have Stories t
October 2025 Medical News Summary
State Laws Aim to Bring Internationally Trained Physicians to Underserved Areas, but Barriers Abound; Oral Microbiome Composition Linked to Pancreatic Cancer Risk Related Content: Oral Microbiome Composition Linked to Pancreatic Cancer Risk State Laws Aim to Bring Internationally Trained Physicians to Underserved Areas, but Barriers Abound
Understanding Cardiac Long COVID
A new European Society of Cardiology clinical consensus statement deals with cardiovascular disease prevention and management in COVID-19, including cardiac long COVID. The report's lead author, Vassilios Vassiliou, MBBS, PhD, MA, discusses the guidance and key questions that remain about COVID-19 and the heart. Related Content: New Guidance on Cardiovascular Disease and COVID-19—From Infection
Acetaminophen Use in Pregnancy and Risk of Autism
Epidemiologist Brian Lee, PhD, discusses his study on acetaminophen use during pregnancy and children's risk of autism and other neurodevelopmental disorders in this interview with JAMA Deputy Editor Linda Brubaker, MD. Related Content: Acetaminophen Use in Pregnancy—Study Author Explains the Data
September 2025 Medical News Summary
Ultraprocessed Foods and Cardiometabolic Health—New Report on a "Growing Public Health Challenge"; New Analysis of Women's Health Initiative Data Aims to "Clear the Air" Over Menopausal Hormone Therapy Related Content: New Analysis of Women's Health Initiative Data Aims to "Clear the Air" Over Menopausal Hormone Therapy Ultraprocessed Foods and Cardiometabolic Health—New Report on a "Growing Pub
Cardiovascular Highlights From ESC 2025
Updates on GLP-1 drugs in heart failure, β-blockers after myocardial infarction, the shingles vaccine, and more: Felix Mahfoud, MD, chair of the Department of Cardiology at University Hospital Basel, shares clinical research highlights from the recent European Society of Cardiology Congress. Related Content: GLP-1 Drugs in Heart Failure, β-Blockers After MI, the Shingles Vaccine, and More From E
How Did Cystic Fibrosis Go From Fatal to Treatable?
Pulmonologist Michael J. Welsh, MD, is the co-recipient of the 2025 Lasker-DeBakey Clinical Medical Research Award for his research on cystic fibrosis. In this interview, he discusses his early clinical encounters with the disease, the foundational work that led to the lifesaving drug Trikafta, and future directions for cystic fibrosis treatment. Related Content: How Cystic Fibrosis Went From Fa
August 2025 Medical News Summary
What Is 7-OH?; Real-World Experience With Antiamyloid Therapies for Alzheimer Disease; FDA Panel on SSRIs and Pregnancy Lacked Nuance, Experts Say Related Content: What to Know About 7-OH, the New Vape Shop Hazard Treating Alzheimer Disease With Antiamyloid Therapies—The Real-World Experience Grows FDA Panel Casts SSRIs During Pregnancy as Risky—Many Experts Disagree
July 2025 Medical News Summary
The Effects of Newly Changed Guidance on COVID-19 Shots During Pregnancy; Heart Disease Deaths Have Changed; Progress Toward a Norovirus Vaccine Related Content: The CDC No Longer Recommends COVID-19 Shots During Pregnancy—Now What? New Research Finds Long-Term Shifts in Heart Disease Mortality Is There a Norovirus Vaccine on the Horizon?
Socially Assistive Robots, Part 2
In this follow-up to a 2017 interview with JAMA Medical News, the University of Southern California's Maja Matarić, PhD, the computer scientist who pioneered the field of socially assistive robotics, discusses how artificial intelligence is advancing the field in areas ranging from autism to physical rehabilitation to anxiety and depression. Related Content: Social Robots That Help Support Peopl
Clinical Highlights From ASCO 2025
Kimmie Ng, MD, MPH, a JAMA associate editor and associate chief of the Division of Gastrointestinal Oncology at the Dana-Farber Cancer Institute, shares highlights from the American Society of Clinical Oncology's annual meeting, including new research on diet, exercise, and cancer survival and the best time of day for treatment. Related Content: Lifestyle and Cancer Survival, the Best Time of Da
June 2025 Medical News Summary
New NIH-FDA Partnership Targets Nutrition Research Gaps; First Blood Test for Alzheimer Biomarkers Receives FDA Clearance; A Growing Movement to Care for Caregivers Related Content: New Federal Program Seeks to Bridge Nutrition Research With Regulatory Policy What to Know About the First FDA-Cleared Blood Test for Alzheimer Biomarkers As the US Ages, a Growing Movement Aims to Care for Caregiver
AI-Based Analysis for Parkinsonism
Delaying diagnosis of parkinsonism can mean delaying care. In a study recently published in JAMA Neurology, David Vaillancourt, PhD, and colleagues tested the ability of an AI model to differentiate between Parkinson disease and other neurodegenerative disorders when paired with MRI. He joins JAMA and JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH to discuss. Related Content: A Large Proportion
May 2025 Medical News Summary
Federal Funds for Rural Health Care May Be Cut; Why the IV Fluid Shortage After Hurricane Helene Was Years in the Making; Surge in US Sports Betting Raises Public Health Concerns Related Content: Federal Funds for Rural Health Care Are on the Chopping Block—Here's What That Could Mean IV Fluid Shortages Persist Months After Hurricane Helene Hit a Supplier—Hospitals Have Had to Adapt The Hidden H
When Do Nudges Help?
Susan Athey, PhD, of Standford University joins JAMA+ AI Editor in Chief Roy H. Perlis, MD, MSc, to discuss her research on machine learning to target behavioral nudges for college students and their potential implications for health care. Related Content: How an Economist's Application of Machine Learning to Target Nudges Applies to Precision Medicine
Highlights From the American College of Cardiology's 2025 Scientific Session
Ajay J. Kirtane, MD, SM, a professor of medicine at Columbia University Irving Medical Center, discusses late-breaking clinical research presented at the annual meeting of the American College of Cardiology in an interview with JAMA Medical News Director Jennifer Abbasi. Related Content: Heart Health Highlights From ACC—Marathon Runners and Mortality, Oral GLP-1 Drugs, and More
April 2025 Medical News Summary
Axe Falls on Federal Health Workforce; Experts Say CDC Cuts Will Cost Lives Related Content: "Guaranteed Pandemonium" as HHS Secretary Slashes Federal Health Workforce Experts Say Abrupt and "Staggering" CDC Cuts Will Cost Lives
Real-World Performance of AI in Screening for Diabetic Retinopathy
Diabetic retinopathy remains a leading cause of preventable blindness worldwide, and AI may facilitate screening, if such models continue to perform well when they are deployed in the real world. Coauthors Arthur Brant, MD, of Stanford University, and Sunny Virmani, MS, of Google join JAMA+ AI Editor in Chief Roy H. Perlis, MD, MSc, to discuss a new study published in JAMA Network Open. Related C
Can Open-Source LLMs Compete With Proprietary Ones for Complex Diagnoses?
A recent study published in JAMA Health Forum suggests that institutions may be able to deploy custom open-source large language models (LLMs) that run locally without sacrificing data privacy or flexibility. Coauthors Thomas A. Buckley, BS, and Arjun K. Manrai, PhD, from the Department of Biomedical Informatics at Harvard Medical School join JAMA+ AI Editor in Chief Roy H. Perlis, MD, MSc, to dis
March 2025 Medical News Summary
The US Is Suing Pharmacies for Aiding in the Opioid Crisis; Texas Measles Outbreak Spurs Call for Stronger Vaccine Advocacy; Study Finds Sleep-Related Infant Deaths Are on the Rise Related Content: US Government Sues Pharmacy Chains CVS and Walgreens for Their Alleged Role in the Opioid Epidemic Amid Texas Measles Outbreak, Clinicians Struggle to Offset Increasing Vaccine Hesitancy Amid Decreasi
Rethinking Race in Prenatal Screening for Open Neural Tube Defects
Correction: This podcast has been updated to add additional context on the frequency of false positives. Open neural tube defects affect approximately 1 in 1400 births. Daniel Herman, MD, PhD, of the University of Pennsylvania Perelman School of Medicine joins JAMA+ AI Editor in Chief Roy H. Perlis, MD, MSc, to discuss a quality improvement study examining the need to continue to incorporate race
AI's Role in Advancing Equity for Individuals With Developmental Disabilities
Artificial intelligence (AI) in health care is advancing, despite concerns about how its use may impact health disparities. Dimitri Christakis, MD, MPH, chief health officer at Special Olympics, joins JAMA Associate Editor Yulin Hswen, ScD, MPH, to discuss AI's potential role in improving health care delivery for people with intellectual and developmental disabilities. Related Content: How AI Co
Prescreening for Clinical Trial Eligibility Using Large Language Models
A recent study showed AI-assisted screening using a large language model tool reduced time to determine trial eligibility compared with manual methods. Author Alexander J. Blood, MD, MSc, cardiologist at Brigham and Women's Hospital, and Associate Director of the Accelerator for Clinical Transformation Research Group at Harvard Medical School joins JAMA Associate Editor Yulin Hswen, ScD, MPH, to d
Machine Learning for Earlier Diagnosis of Schizophrenia
In a recent study published in JAMA Psychiatry, researchers reported that a machine learning model was able to stratify risk for subsequent diagnosis of schizophrenia or bipolar disorder among individuals already receiving psychiatric treatment. Coauthor Søren Dinesen Østergaard, PhD, of Aarhus University in Denmark joins JAMA+ AI Editor in Chief Roy H. Perlis, MD, MSc, to discuss. Related Conten
The 5 Ways Engineers Plan to Curb Antimicrobial Resistance
A recent report from the Engineering Research Visioning Alliance emphasizes the urgent need for engineering-directed research to mitigate the growing threat of antimicrobial resistance. Anita Shukla, PhD, a professor of engineering at Brown University, discusses its findings with JAMA Medical News Associate Managing Editor Kate Schweitzer and presents several key opportunities. Related Content:
